Molecular cloning of feline interferon-γ-inducing factor (interleukin-18) and its expression in various tissues

Veterinary Immunology and Immunopathology

Volumn 79, Issue 3-4, 2001, Pages 209-218

  Ishizaka, Tomomichi ^a   Setoguchi, Asuka ^a   Masuda, Kenichi ^a   Ohno, Koichi ^a   Tsujimoto, Hajime ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Cat; Cloning; Cytokine; Interleukin 18

Indexed keywords

COMPLEMENTARY DNA; INTERLEUKIN 18;

AMINO ACID SEQUENCE; ANIMAL TISSUE; ARTICLE; BRAIN; CAT; GENE EXPRESSION; LIVER; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; SPLEEN;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CATS; CLONING, MOLECULAR; DNA, COMPLEMENTARY; DOGS; HUMANS; INTERLEUKIN-18; LIVER; MICE; MOLECULAR SEQUENCE DATA; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS, DNA; SEQUENCE HOMOLOGY, AMINO ACID; SPLEEN; TELENCEPHALON;

ANIMALIA; CANIS FAMILIARIS; FELIDAE; FELIS CATUS;

EID: 0035972876     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-2427(01)00266-5     Document Type: Article

References (29)

1. Akita K., Ohtsuki T., Nukada Y., Tanimoto T., Namba M., Okura T., Takakura-Yamamoto R., Torigoe K., Gu Y., Su M.S.S., Fujii M., Satoh-Itoh M., Yamamoto K., Kohno K., Ikeda M., Kurimoto M. Involvement of caspase-1 and caspase-3 in the production and processing of mature human interleukin 18 in monocytic THP-1 cells. J. Biol. Chem. 272:1997;26595-26603.
2. Argyle D.J., McGillivery C., Nicolson L., Onions D.E. Cloning, sequencing, and characterization of dog interleukin-18. Immunogenetics. 49:1999;541-543.
3. Bush K., Day N.K., Kraus L.A., Good R.A., Bradley W.G. Molecular cloning of feline interleukin 12 p35 reveals the conservation of leucine-zipper motifs present in human and murine IL-12 p35. Mol. Immunol. 31:1994;1373-1374.
4. Culhane A.C., Hall M.D., Rothwell N.J., Luheshi G.N. Cloning of rat brain interleukin-18 cDNA. Mol. Psychiatry. 3:1998;326-362.
5. Dao T., Ohashi K., Kayano T., Kurimoto M., Okamura H. Interferon-gamma-inducing factor, a novel cytokine, enhances Fas ligand-mediated cytotoxicity of murine T helper 1 cells. Cell. Immunol. 173:1996;230-235.
6. Dao T., Mehal W.Z., Crispe I.N. IL-18 augments perforin-dependent cytotoxicity of liver NK-T cells. J. Immunol. 161:1998;2217-2222.
7. Fehr D., Dean G.A., Huder J., Fan Z., Huettner S., Higgins J.W., Pedersen N.C., Lutz H. Nucleotide and predicted peptide sequence of feline interleukin-12 (IL-12). DNA Seq. 8:1997;77-82.
8. Fujioka N., Akazawa R., Ohashi K., Fujii M., Ikeda M., Kurimoto M. Interleukin-18 protects mice against acute herpes simplex virus type 1 infection. J. Virol. 73:1999;2401-2409.
9. Gu Y., Kuida K., Tsutsui H., Ku G., Hsiao K., Fleming M.A., Hayashi N., Higashino K., Okamura H., Nakanishi K., Kurimoto M., Tanimoto T., Flavell R.A., Sato V., Harding M.W., Livingston D.J., Su M.S. Activation of interferon-gamma inducing factor mediated by interleukin-1beta converting enzyme. Science. 275:1997;206-209.
10. Hashimoto W., Osaki T., Okamura H., Robbins P.D., Kurimoto M., Nagata S., Lotze M.T., Tahara H. Differential antitumor effects of administration of recombinant IL-18 or recombinant IL-12 are mediated primarily by Fas-Fas ligand- and perforin-induced tumor apoptosis, respectively. J. Immunol. 163:1999;583-589.
11. Howard, A.D., Kostura, M.J., Thornberry, N., Ding, G.J., Limjuco, G., Weidner, J., Salley, J.P., Hogquist, K.A., Chaplin, D.D., Mumford, R.A., et al., 1991. IL-1-converting enzyme requires aspartic acid residues for processing of the IL-1 beta precursor at two distinct sites and does not cleave 31 kDa IL-1 alpha. J. Immunol. 147, 2964-2969.
12. Kawakami K., Qureshi M.H., Zhang T., Okamura H., Kurimoto M., Saito A. IL-18 protects mice against pulmonary and disseminated infection with Cryptococcus neoformans by inducing IFN-gamma production. J. Immunol. 159:1997;5528-5534.
13. McFarland E.J., Harding P.A., MaWhinney S., Schooley R.T., Kuritzkes D.R. In vitro effects of IL-12 on HIV-1-specific CTL lines from HIV-1-infected children. J. Immunol. 161:1998;513-519.
14. Micallef M.J., Tanimoto T., Kohno K., Ikeda M., Kurimoto M. Interleukin 18 induces the sequential activation of natural killer cells and cytotoxic T lymphocytes to protect syngeneic mice from transplantation with Meth A sarcoma. Cancer Res. 57:1997;4557-4563.
15. Okamoto I., Kohno K., Tanimoto T., Ikegami H., Kurimoto M. Development of CD8+ effector T cells is differentially regulated by IL-18 and IL-12. J. Immunol. 162:1999;3202-3211.
16. Okamura, H., Tsutsi, H., Komatsu, T., Yutsudo, M., Hakura, A., Tanimoto, T., Torigoe, K., Okura, T., Nukada, Y., Hattori, K., et al., 1995. Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature 378, 88-91.
17. Osaki T., Hashimoto W., Gambotto A., Okamura H., Robbins P.D., Kurimoto M., Lotze M.T., Tahara H. Potent antitumor effects mediated by local expression of the mature form of the interferon-gamma inducing factor, interleukin-18 (IL-18). Gene Ther. 6:1999;808-815.
18. Pappo I., Tahara H., Robbins P.D., Gately M.K., Wolf S.F., Barnea A., Lotze M.T. Administration of systemic or local interleukin-2 enhances the anti-tumor effects of interleukin-12 gene therapy. J. Surg. Res. 58:1995;218-226.
19. Prinz M., Hanisch U.K. Murine microglial cells produce and respond to interleukin-18. J. Neurochem. 72:1999;2215-2218.
20. Robertson M.J., Cameron C., Atkins M.B., Gordon M.S., Lotze M.T., Sherman M.L., Ritz J. Immunological effects of interleukin 12 administered by bolus intravenous injection to patients with cancer. Clin. Cancer Res. 5:1999;9-16.
21. Rook A.H., Wood G.S., Yoo E.K., Elenitsas R., Kao D.M., Sherman M.L., Witmer W.K., Rockwell K.A., Shane R.B., Lessin S.R., Vonderheid E.C. Interleukin-12 therapy of cutaneous T-cell lymphoma induces lesion regression and cytotoxic T-cell responses. Blood. 94:1999;902-908.
22. Tahara H., Zeh H.J. III, Storkus W.J., Pappo I., Watkins S.C., Gubler U., Wolf S.F., Robbins P.D., Lotze M.T. Fibroblasts genetically engineered to secrete interleukin 12 can suppress tumor growth and induce antitumor immunity to a murine melanoma in vivo. Cancer Res. 54:1994;182-189.
23. Tanaka-Kataoka M., Kunikata T., Takayama S., Iwaki K., Ohashi K., Ikeda M., Kurimoto M. In vivo antiviral effect of interleukin 18 in a mouse model of vaccinia virus infection. Cytokine. 11:1999;593-599.
24. Thornberry, N.A., Bull, H.G., Calaycay, J.R., Chapman, K.T., Howard, A.D., Kostura, M.J., Miller, D.K., Molineaux, S.M., Weidner, J.R., Aunins, J., et al., 1992. A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes. Nature 356, 768-774.
25. Ushio S., Namba M., Okura T., Hattori K., Nukada Y., Akita K., Tanabe F., Konishi K., Micallef M., Fujii M., Torigoe K., Tanimoto T., Fukuda S., Ikeda M., Okamura H., Kurimoto M. Cloning of the cDNA for human IFN-gamma-inducing factor, expression in Escherichia coli, and studies on the biologic activities of the protein. J. Immunol. 156:1996;4274-4279.
26. Wildbaum G., Youssef S., Grabie N., Karin N. Neutralizing antibodies to IFN-gamma-inducing factor prevent experimental autoimmune encephalomyelitis. J. Immunol. 161:1998;6368-6374.
27. Yamanaka K., Hara I., Nagai H., Miyake H., Gohji K., Micallef M.J., Kurimoto M., Arakawa S., Kamidono S. Synergistic antitumor effects of interleukin-12 gene transfer and systemic administration of interleukin-18 in a mouse bladder cancer model. Cancer Immunol. Immunother. 48:1999;297-302.
28. Yoshimoto T., Takeda K., Tanaka T., Ohkusu K., Kashiwamura S., Okamura H., Akira S., Nakanishi K. IL-12 up-regulates IL-18 receptor expression on T cells, Th1 cells, and B cells: synergism with IL-18 for IFN-gamma production. J. Immunol. 161:1998;3400-3407.
29. Zhang T., Kawakami K., Qureshi M.H., Okamura H., Kurimoto M., Saito A. Interleukin-12 (IL-12) and IL-18 synergistically induce the fungicidal activity of murine peritoneal exudate cells against Cryptococcus neoformans through production of gamma interferon by natural killer cells. Infect. Immunol. 65:1997;3594-3599.